| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/03/2006 | US7115583 Microbubble compositions and methods for oligonucleotide delivery |
| 10/03/2006 | US7115580 antisense compound targeted to human B7; use with antiinflammatory agents or immunosuppressants; modulation of T cell activation |
| 10/03/2006 | US7115579 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 10/03/2006 | US7115574 System and method for support legacy operating system booting in a legacy-free system |
| 10/03/2006 | US7115573 Prodrug compounds with an isoleucine |
| 10/03/2006 | US7115572 Indolicidin analogs with anti-microbial activity |
| 10/03/2006 | US7115571 of given amino acid sequence; D-amino acid linkage makes peptides resistant to proteolytic degradation in vivo; same activity as native IL-3 and also have neurotrophic activity |
| 10/03/2006 | US7115570 using human type VI adenylyl cyclase (hAC6) polypeptide, to screen for agonists and antagonists |
| 10/03/2006 | US7115569 Exendins, exendin agonists, and methods for their use |
| 10/03/2006 | US7115568 Methods using TCF II |
| 10/03/2006 | US7115567 Protein for use in the treatment of inflammation, allergies, asthma and leukemias |
| 10/03/2006 | US7115566 For improved drug delivery |
| 10/03/2006 | US7115565 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 10/03/2006 | US7115564 prolonged serum half-life to permit treatment regimens of about once every 5-7 days or longer, while retaining antibacterial properties in vivo |
| 10/03/2006 | US7115563 vitamin; a metal salt that provides metal ions in vivo; and insulin or a growth hormone |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 10/03/2006 | US7115561 for nasal administration across the mucous membrane, comprising a free-flowing powder of ion exchange resin divinylbenzene crosslinked polystyrenesulfonic acid or salts thereof ionically bound to the therapeutic peptide such as nesiritide |
| 10/03/2006 | US7115560 of given amino acid sequence, for reducing gastric acid or pepsinogen secretion |
| 10/03/2006 | US7115559 Administering factor XIII to patients afflicted with bleeding due to a coumarin anticoagulant-induced vitamin K deficiency |
| 10/03/2006 | US7115557 Administering tumor necrosis factor inhibitors, interleukin -1, -6, or -8 inhibitors, FAS (ligand) gene/protein inhibitors or interferon gamma inhibitors; nerve disorder treatments |
| 10/03/2006 | US7115556 Use of anti-prolactin agents to treat proliferative conditions |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115418 Methods of proliferating undifferentiated neural cells |
| 10/03/2006 | US7115415 Forstimulating or inhibiting angiogenesis and/or cardiovascularization in mammals |
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115410 Purified protein that exhibits beta -secretase activity, is expressed from a bacterial source; treating amyloidogenic diseases such as Alzheimer's disease. |
| 10/03/2006 | US7115402 Isolated nucleic acid encoding polypeptide of given sequence; use in diagnosis, treatment, and/or prevention of various diseases |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115397 Methods and kits for purifying his-tagged proteins |
| 10/03/2006 | US7115396 Protein scaffolds for antibody mimics and other binding proteins |
| 10/03/2006 | US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115390 Connective tissue growth factor fragments and methods and uses thereof |
| 10/03/2006 | US7115380 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 10/03/2006 | US7115375 Methods of diagnosing renal tumors by determining the expression level of RNA encoding the HGPRBMY18 polypeptide |
| 10/03/2006 | US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
| 10/03/2006 | US7115282 Encapsulated perfumes, flavors, active materials; free-flowing powders |
| 10/03/2006 | US7115272 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 10/03/2006 | US7115271 Protein D—an IgD-binding protein of Haemophilus influenzae |
| 10/03/2006 | US7115268 Peptides derived from homologous sequences of the family of staphylococcal and streptococcal toxins, which may be polymeric, that provide protection against, or reduce the severity of toxic shock and septic shock from bacterial infections |
| 10/03/2006 | US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation. |
| 10/03/2006 | US7115266 Angiotensin peptide-carrier conjugates and uses thereof |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 10/03/2006 | US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 10/03/2006 | CA2254889C A promoter gene for a porcine complement inhibitor |
| 10/03/2006 | CA2250906C Enteric-coated pharmaceutical compositions of mycophenolate |
| 10/03/2006 | CA2213188C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 10/03/2006 | CA2082495C A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| 10/03/2006 | CA2080504C Pharmaceutical compositions comprising il-6 |
| 10/03/2006 | CA2063822C Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 09/28/2006 | WO2006102653A2 Methods and compositions for treating insulin resistance and obesity-induced diseases |
| 09/28/2006 | WO2006102521A2 Methods of determining compounds useful in the treatment of bipolar disorder and methods of treating such disorders |
| 09/28/2006 | WO2006102461A2 Influenza therapeutic |
| 09/28/2006 | WO2006102438A2 Methods and compositions for irrigation of mucosal tissues |
| 09/28/2006 | WO2006102267A2 New neuronal pain pathway |
| 09/28/2006 | WO2006102192A1 A factor and method to increase permeability across a biomembrane using antiproliferative factor |
| 09/28/2006 | WO2006102072A2 Use of a pa131 polypeptide in treatment of atherosclerosis |
| 09/28/2006 | WO2006102070A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | WO2006102069A2 Methods and compositions for the treatment of hypertension and gastrointestinal disorders |
| 09/28/2006 | WO2006102068A2 Methods and compositions for derepression of iap-inhibited caspase |
| 09/28/2006 | WO2006101910A2 Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems |
| 09/28/2006 | WO2006101909A2 Combination therapy for treating or preventing diseases |
| 09/28/2006 | WO2006101809A1 Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006101740A2 Compounds having activity in correcting mutant-cftr processing and uses thereof |
| 09/28/2006 | WO2006101691A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | WO2006101540A1 Reduction of postoperative pain medication |
| 09/28/2006 | WO2006101535A1 Inhibition of proteasome function to potentiate the proapoptotic and antitumor activity of cytokines |
| 09/28/2006 | WO2006101422A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | WO2006101273A1 Prophylactic/therapeutic agent for cancer |
| 09/28/2006 | WO2006101187A1 Peptides that increase collagen or hyaluronic acid production |
| 09/28/2006 | WO2006101181A1 Composition for prevention or improvement of liver dysfunction, and method for preventing or improving liver dysfunction |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006101140A1 Novel protease, microorganism producing the same, and application thereof |
| 09/28/2006 | WO2006100501A1 Statherin peptide and use in medicine |
| 09/28/2006 | WO2006100468A1 Treatment of laminitis |
| 09/28/2006 | WO2006100430A2 Polypeptides |
| 09/28/2006 | WO2006100021A1 Use of the mst protein for the treatment of a thromboembolic disorder |
| 09/28/2006 | WO2006099739A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | WO2006099701A1 Inhibitor of endogenous human interferon - gamma |
| 09/28/2006 | WO2006085974A3 Amphiphilic dendritic dipeptides & their self-assembly into helical pores |
| 09/28/2006 | WO2006083761A3 Solvent/polymer solutions as suspension vehicles |
| 09/28/2006 | WO2006059113A3 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2006045319A3 Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure |
| 09/28/2006 | WO2006044294A3 Human protein c analogs |
| 09/28/2006 | WO2006031330A3 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 09/28/2006 | WO2005074650A3 Modified human four helical bundle polypeptides and their uses |
| 09/28/2006 | WO2005072292A3 Methods for enhancing radiation therapy |
| 09/28/2006 | WO2005065718A8 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 09/28/2006 | WO2005037853A3 Side chain deuterated amino acids and methods of use |
| 09/28/2006 | WO2004080404A3 Il-2 transmembrane constructs |
| 09/28/2006 | WO2004024090A3 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 09/28/2006 | WO2003103572A3 Modified glucagon-like peptide-1 analogs |
| 09/28/2006 | WO2003076578A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |